Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment : A Systematic Review and Meta-Analysis of Randomised Clinical Trials

Kleiner Dénes and Horváth István László and Bunduc Stefania and Gergő Dorottya and Lugosi Katalin and Fehérvári Péter and Hegyi Péter and Csupor Dezső: Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment : A Systematic Review and Meta-Analysis of Randomised Clinical Trials.
CURRENT NEUROPHARMACOLOGY, 21 (12). pp. 2505-2515. ISSN 1570-159X (2023)

[thumbnail of CN-2022-0251.R1-MS.pdf] Text
CN-2022-0251.R1-MS.pdf - Accepted Version
Closed access: Repository staff only

Download (1MB) | Request a copy
Item Type: Journal Article
Journal or Publication Title: CURRENT NEUROPHARMACOLOGY
Date: 2023
Volume: 21
Number: 12
Page Range: pp. 2505-2515
ISSN: 1570-159X
Faculty/Unit: Faculty of Pharmacy
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 34088338
DOI azonosító: https://doi.org/10.2174/1570159X21666230727094431
Date Deposited: 2023. Nov. 23. 11:07
Last Modified: 2023. Nov. 23. 11:07
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/28918
Web of Science® Times Cited: 4 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year